| Financial Year |
March 31 2023 |
| Monetary Funds |
2,078,216,791.59 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
424,410,260.62 |
| Advances to Suppliers |
146,379,193.15 |
| Other Receivables |
54,902,493.35 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,142,196,571.34 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
10,004,641.01 |
| Other Current Assets |
34,254,594.20 |
| Total Current Assets |
3,890,364,545.26 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
7,948,822.00 |
| Long-term Equity Investment |
3,923,781,173.28 |
| Investment Properties |
-- |
| Fixed Assetes |
22,135,249.93 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
1,289,355.86 |
| R&D expenses |
-- |
| Goodwill |
15,355,143.09 |
| Long-Term Deferred and Prepaid Expenses |
3,005,308.10 |
| Deferred Income Tax Assets |
96,747,097.72 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
5,463,548,071.64 |
| Total Assets |
9,353,912,616.90 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
229,168,795.88 |
| Accounts Received In Advance |
2,675,199.22 |
| Employee Compensation Payable |
11,823,129.00 |
| Taxes Payable |
69,319,944.17 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
11,739,116.34 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
32,122,616.25 |
| Other Current Liabilities |
6,390,716.68 |
| Sub-Total of Current Liabilities |
783,998,766.63 |
| Long-term Loans |
12,000,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
24,364,763.95 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
164,275,830.88 |
| Total Liabilities |
948,274,597.51 |
| Paid-In Capital(Or Share Stock) |
2,933,608,432.00 |
| Capital Surplus |
1,972,348,671.53 |
| Surplus Reserve |
415,210,798.22 |
| LESS:Treasury Stock |
150,003,952.67 |
| Undistributed Profits |
3,142,990,499.91 |
| Minority Stockholder's Interest |
5,808,528.75 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
8,399,829,490.64 |
| Owner's Equity（Stockholder's Equity） |
8,405,638,019.39 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
9,353,912,616.90 |
